In today’s recent session, 0.42 million shares of the TG Therapeutics Inc (NASDAQ:TGTX) have been traded, and its beta is 2.28. Most recently the company’s share price was $35.51, and it changed around -$0.11 or -0.31% from the last close, which brings the market valuation of the company to $5.58B. TGTX at last check was trading at a discount to its 52-week high of $36.94, offering almost -4.03% off that amount. The share price’s 52-week low was $12.93, which indicates that the recent value has risen by an impressive 63.59% since then.
TG Therapeutics Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.38. If we narrow it down even further, the data shows that 0 out of 8 analysts rate the stock as a Sell; another 2 rate it as Overweight. Among the rest, 0 recommended TGTX as a Hold, whereas 5 deemed it a Buy, and 1 rated it as Underweight.
TG Therapeutics Inc (NASDAQ:TGTX) trade information
Instantly TGTX has been showing red trend so far today with a performance of -0.31% on intraday trading today. The performance over the last five days has remained in the green territory. The rise to weekly highs of 36.94 on recent trading dayincreased the stock’s daily price by 3.87%. The company’s shares are currently up 17.97% year-to-date, but still up 21.03% over the last five days. On the other hand, TG Therapeutics Inc (NASDAQ:TGTX) is 12.80% up in the 30-day period.
The consensus price target as assigned by Wall Street analysts is $27.5, which translates to bulls needing to decrease their stock price by -29.13% from its current value. Analyst projections state that TGTX is forecast to be at a low of $27.5 and a high of $27.5.
TG Therapeutics Inc (NASDAQ:TGTX)’s Major holders
BLACKROCK INC., with 7.7891% or 11.39 million shares worth $202.6 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
iShares Core S&P Smallcap ETF and Vanguard Total Stock Market Index Fund were the top two Mutual Funds as of Dec 31, 2024. The former held 8.61 shares worth $303.98 million, making up 5.53% of all outstanding shares. On the other hand, Vanguard Total Stock Market Index Fund held roughly 4.37 shares worth around $154.17 million, which represents about 2.81% of the total shares outstanding.
